Fernando Aranda
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 48
- Immunotherapy and Immune Responses 33
- T-cell and B-cell Immunology 9
- interferon and immune responses 3
- Oncology 30
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 5
- Co-authors
- Guido Kroemer (24 shared papers)Lorenzo Galluzzi (21 shared papers)Laurence Zitvogel (20 shared papers)Alexander M.M. Eggermont (17 shared papers)Erika Vacchelli (11 shared papers)Jérôme Galon (16 shared papers)Catherine Sautès‐Fridman (8 shared papers)Éric Tartour (10 shared papers)
- Journals
- OncoImmunology (28 papers)Frontiers in Immunology (6 papers)Journal for ImmunoTherapy of Cancer (5 papers)Oncotarget (3 papers)International review of cytology (3 papers)
- Partner nations
- SpainFranceUnited States
In The Last Decade
Fernando Aranda
79 papers receiving 4.4k citations
Fernando Aranda's Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 1.6k
- Oncology 1.7k
- Biological Psychiatry 70
- Aging 36
- Cancer Research 186
Countries citing papers authored by Fernando Aranda
This map shows the geographic impact of Fernando Aranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Aranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Aranda more than expected).
Fields of papers citing papers by Fernando Aranda
This network shows the impact of papers produced by Fernando Aranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Aranda. The network helps show where Fernando Aranda may publish in the future.
Co-authors
The 25 scholars most cited alongside Fernando Aranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Consensus guidelines for the detection of immunogenic cell death Hit paper breakdown → | 2014 | 725 |
| 2 | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance Hit paper breakdown → | 2016 | 440 |
| 3 | 2014 | 379 | |
| 4 | 2014 | 307 | |
| 5 | 2015 | 261 | |
| 6 | 2014 | 134 | |
| 7 | 2015 | 109 | |
| 8 | 2019 | 104 | |
| 9 | 2015 | 99 | |
| 10 | 2013 | 98 | |
| 11 | 2020 | 98 | |
| 12 | 2014 | 96 | |
| 13 | 2022 | 84 | |
| 14 | 2016 | 74 | |
| 15 | 2014 | 72 | |
| 16 | 2016 | 70 | |
| 17 | 2014 | 67 | |
| 18 | 2014 | 67 | |
| 19 | 2011 | 66 | |
| 20 | 2017 | 65 |
About Fernando Aranda
Fernando Aranda is a scholar working on Immunology, Oncology, Genetics, Epidemiology and Molecular Biology, having authored 81 papers that have together received 4.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), Cancer Immunotherapy and Biomarkers (24 papers), T-cell and B-cell Immunology (9 papers), Virus-based gene therapy research (7 papers), CAR-T cell therapy research (5 papers), TGF-β signaling in diseases (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.7k citations), Biological Psychiatry (70 citations), Aging (36 citations) and Cancer Research (186 citations). Fernando Aranda has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Guido Kroemer, Lorenzo Galluzzi, Laurence Zitvogel, Alexander M.M. Eggermont, Erika Vacchelli, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Isabelle Cremer and Radek Špíšek. Their work appears in journals such as OncoImmunology, Frontiers in Immunology, Journal for ImmunoTherapy of Cancer, Oncotarget and International review of cytology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.